Connection

Louis Luttrell to Humans

This is a "connection" page, showing publications Louis Luttrell has written about Humans.
Connection Strength

0.825
  1. Manifold roles of ?-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9. Sci Signal. 2018 09 25; 11(549).
    View in: PubMed
    Score: 0.024
  2. The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling. Pharmacol Rev. 2017 07; 69(3):256-297.
    View in: PubMed
    Score: 0.022
  3. Translating in vitro ligand bias into in vivo efficacy. Cell Signal. 2018 01; 41:46-55.
    View in: PubMed
    Score: 0.022
  4. GPCR Signaling Rides a Wave of Conformational Changes. Cell. 2016 Oct 20; 167(3):602-603.
    View in: PubMed
    Score: 0.021
  5. Hyperparathyroidism-jaw Tumor Syndrome: An Overlooked Cause of Severe Hypercalcemia. Am J Med Sci. 2016 Sep; 352(3):302-5.
    View in: PubMed
    Score: 0.020
  6. The conformational signature of ?-arrestin2 predicts its trafficking and signalling functions. Nature. 2016 Mar 31; 531(7596):665-8.
    View in: PubMed
    Score: 0.020
  7. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism. Mol Pharmacol. 2015 Sep; 88(3):579-88.
    View in: PubMed
    Score: 0.019
  8. Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentation. Methods. 2016 Jan 01; 92:51-63.
    View in: PubMed
    Score: 0.019
  9. Delineation of a conserved arrestin-biased signaling repertoire in vivo. Mol Pharmacol. 2015 Apr; 87(4):706-17.
    View in: PubMed
    Score: 0.019
  10. Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis. J Biol Chem. 2014 Sep 19; 289(38):26155-26166.
    View in: PubMed
    Score: 0.018
  11. Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery. Mol Endocrinol. 2014 Mar; 28(3):281-94.
    View in: PubMed
    Score: 0.017
  12. Arrestin-dependent activation of ERK and Src family kinases. Handb Exp Pharmacol. 2014; 219:225-57.
    View in: PubMed
    Score: 0.017
  13. Emergent biological properties of arrestin pathway-selective biased agonism. J Recept Signal Transduct Res. 2013 Jun; 33(3):153-61.
    View in: PubMed
    Score: 0.016
  14. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity. Methods Enzymol. 2013; 522:229-62.
    View in: PubMed
    Score: 0.016
  15. Arrestins as regulators of kinases and phosphatases. Prog Mol Biol Transl Sci. 2013; 118:115-47.
    View in: PubMed
    Score: 0.016
  16. Arrestin pathways as drug targets. Prog Mol Biol Transl Sci. 2013; 118:469-97.
    View in: PubMed
    Score: 0.016
  17. Preface. The molecular biology of arrestins. Prog Mol Biol Transl Sci. 2013; 118:xv.
    View in: PubMed
    Score: 0.016
  18. Phospholipase C and protein kinase C-? 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation. Mol Endocrinol. 2011 Dec; 25(12):2144-56.
    View in: PubMed
    Score: 0.015
  19. 'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass? Br J Pharmacol. 2011 Sep; 164(1):59-67.
    View in: PubMed
    Score: 0.015
  20. Brave new world? Arrestin pathway bias in drug design. Endocr Metab Immune Disord Drug Targets. 2011 Jun; 11(2):90-1.
    View in: PubMed
    Score: 0.014
  21. The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling network. J Biol Chem. 2011 Jun 03; 286(22):19880-91.
    View in: PubMed
    Score: 0.014
  22. Refining efficacy: allosterism and bias in G protein-coupled receptor signaling. Methods Mol Biol. 2011; 756:3-35.
    View in: PubMed
    Score: 0.014
  23. Refining efficacy: exploiting functional selectivity for drug discovery. Adv Pharmacol. 2011; 62:79-107.
    View in: PubMed
    Score: 0.014
  24. Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev. 2010 Jun; 62(2):305-30.
    View in: PubMed
    Score: 0.013
  25. Diversity in arrestin function. Cell Mol Life Sci. 2009 Sep; 66(18):2953-73.
    View in: PubMed
    Score: 0.013
  26. Insulin-like growth factor-2/mannose-6 phosphate receptors. Vitam Horm. 2009; 80:667-97.
    View in: PubMed
    Score: 0.012
  27. The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry. 2008 Nov 04; 47(44):11682-92.
    View in: PubMed
    Score: 0.012
  28. Heptahelical terpsichory. Who calls the tune? J Recept Signal Transduct Res. 2008; 28(1-2):39-58.
    View in: PubMed
    Score: 0.011
  29. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription. J Biol Chem. 2008 Jan 25; 283(4):2088-97.
    View in: PubMed
    Score: 0.011
  30. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. J Biol Chem. 2007 Sep 07; 282(36):26150-7.
    View in: PubMed
    Score: 0.011
  31. G protein-coupled receptor signaling complexity in neuronal tissue: implications for novel therapeutics. Curr Alzheimer Res. 2007 Feb; 4(1):3-19.
    View in: PubMed
    Score: 0.011
  32. Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. J Biol Chem. 2006 Oct 20; 281(42):31399-407.
    View in: PubMed
    Score: 0.010
  33. Signal switching, crosstalk, and arrestin scaffolds: novel G protein-coupled receptor signaling in cardiovascular disease. Hypertension. 2006 Aug; 48(2):173-9.
    View in: PubMed
    Score: 0.010
  34. Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome". J Biol Chem. 2006 Jul 14; 281(28):19346-57.
    View in: PubMed
    Score: 0.010
  35. Transmembrane signaling by G protein-coupled receptors. Methods Mol Biol. 2006; 332:3-49.
    View in: PubMed
    Score: 0.010
  36. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts. J Biol Chem. 2005 Sep 16; 280(37):32157-67.
    View in: PubMed
    Score: 0.010
  37. The origins of diversity and specificity in g protein-coupled receptor signaling. J Pharmacol Exp Ther. 2005 Aug; 314(2):485-94.
    View in: PubMed
    Score: 0.009
  38. Composition and function of g protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity. J Mol Neurosci. 2005; 26(2-3):253-64.
    View in: PubMed
    Score: 0.009
  39. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene. 2004 Oct 18; 23(48):7969-78.
    View in: PubMed
    Score: 0.009
  40. Ectodomain shedding-dependent transactivation of epidermal growth factor receptors in response to insulin-like growth factor type I. Mol Endocrinol. 2004 Nov; 18(11):2727-39.
    View in: PubMed
    Score: 0.009
  41. Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminus. J Biol Chem. 2002 Aug 09; 277(32):28631-40.
    View in: PubMed
    Score: 0.008
  42. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A. 2001 Feb 27; 98(5):2449-54.
    View in: PubMed
    Score: 0.007
  43. Aging-related modifications to G protein-coupled receptor signaling diversity. Pharmacol Ther. 2021 07; 223:107793.
    View in: PubMed
    Score: 0.007
  44. Reply to Schierwagen et al.: ?-Arrestins in liver disease. Proc Natl Acad Sci U S A. 2020 11 03; 117(44):27085-27086.
    View in: PubMed
    Score: 0.007
  45. Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC. Diabetes. 2020 11; 69(11):2440-2445.
    View in: PubMed
    Score: 0.007
  46. Pasteurella multocida toxin stimulates mitogen-activated protein kinase via G(q/11)-dependent transactivation of the epidermal growth factor receptor. J Biol Chem. 2000 Jan 21; 275(3):2239-45.
    View in: PubMed
    Score: 0.007
  47. Islet Harvest in Carbon Monoxide-Saturated Medium for Chronic Pancreatitis Patients Undergoing Islet Autotransplantation. Cell Transplant. 2019 Dec; 28(1_suppl):25S-36S.
    View in: PubMed
    Score: 0.007
  48. Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol. 1999 Oct; 162(4):1537-42.
    View in: PubMed
    Score: 0.006
  49. Conformational Sensors and Domain Swapping Reveal Structural and Functional Differences between ?-Arrestin Isoforms. Cell Rep. 2019 09 24; 28(13):3287-3299.e6.
    View in: PubMed
    Score: 0.006
  50. Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J Biol Chem. 1999 May 14; 274(20):13978-84.
    View in: PubMed
    Score: 0.006
  51. Probing Arrestin Function Using Intramolecular FlAsH-BRET Biosensors. Methods Mol Biol. 2019; 1957:309-322.
    View in: PubMed
    Score: 0.006
  52. Analysis of longitudinal semicontinuous data using marginalized two-part model. J Transl Med. 2018 11 06; 16(1):301.
    View in: PubMed
    Score: 0.006
  53. GIT2-A keystone in ageing and age-related disease. Ageing Res Rev. 2018 May; 43:46-63.
    View in: PubMed
    Score: 0.006
  54. Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort. Diabetes Care. 2018 04; 41(4):840-846.
    View in: PubMed
    Score: 0.006
  55. Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy. Stem Cells Transl Med. 2018 01; 7(1):11-19.
    View in: PubMed
    Score: 0.006
  56. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J Biol Chem. 1997 Feb 14; 272(7):4637-44.
    View in: PubMed
    Score: 0.005
  57. S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization. J Lipid Res. 2017 02; 58(2):325-338.
    View in: PubMed
    Score: 0.005
  58. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem. 1996 Aug 09; 271(32):19443-50.
    View in: PubMed
    Score: 0.005
  59. Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis. Int J Biochem Cell Biol. 2016 08; 77(Pt B):240-50.
    View in: PubMed
    Score: 0.005
  60. Plasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes. Diabetes. 2016 Feb; 65(2):498-502.
    View in: PubMed
    Score: 0.005
  61. Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel. Mol Endocrinol. 2015 Jun; 29(6):896-908.
    View in: PubMed
    Score: 0.005
  62. Mycoplasma hominis septic arthritis: two case reports and review. Clin Infect Dis. 1994 Dec; 19(6):1067-70.
    View in: PubMed
    Score: 0.005
  63. Novel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator. J Biol Regul Homeost Agents. 2014 Oct-Dec; 28(4):587-603.
    View in: PubMed
    Score: 0.005
  64. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. J Biol Chem. 2013 Jun 28; 288(26):18872-84.
    View in: PubMed
    Score: 0.004
  65. Textrous!: extracting semantic textual meaning from gene sets. PLoS One. 2013; 8(4):e62665.
    View in: PubMed
    Score: 0.004
  66. Angiotensin II activates NF-?B through AT1A receptor recruitment of ?-arrestin in cultured rat vascular smooth muscle cells. Am J Physiol Cell Physiol. 2013 Jun 15; 304(12):C1176-86.
    View in: PubMed
    Score: 0.004
  67. Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial. Atherosclerosis. 2013 Jun; 228(2):502-7.
    View in: PubMed
    Score: 0.004
  68. Antagonism of catecholamine receptor signaling by expression of cytoplasmic domains of the receptors. Science. 1993 Mar 05; 259(5100):1453-7.
    View in: PubMed
    Score: 0.004
  69. A high-content, live-cell, and real-time approach to the quantitation of ligand-induced ?-Arrestin2 and Class A/Class B GPCR mobilization. Microsc Microanal. 2013 Feb; 19(1):150-70.
    View in: PubMed
    Score: 0.004
  70. Functional signaling biases in G protein-coupled receptors: Game Theory and receptor dynamics. Mini Rev Med Chem. 2012 Aug; 12(9):831-40.
    View in: PubMed
    Score: 0.004
  71. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. Mol Endocrinol. 2012 May; 26(5):833-45.
    View in: PubMed
    Score: 0.004
  72. Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation. Mol Immunol. 2011 Oct; 49(1-2):64-74.
    View in: PubMed
    Score: 0.004
  73. Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors. J Biol Chem. 2010 Nov 05; 285(45):35206-15.
    View in: PubMed
    Score: 0.003
  74. Novel mechanisms in the regulation of G protein-coupled receptor trafficking to the plasma membrane. J Biol Chem. 2010 Oct 29; 285(44):33816-25.
    View in: PubMed
    Score: 0.003
  75. HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate. J Lipid Res. 2010 Sep; 51(9):2619-28.
    View in: PubMed
    Score: 0.003
  76. Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes. J Med Genet. 2010 Jun; 47(6):391-7.
    View in: PubMed
    Score: 0.003
  77. Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders. J Pharmacol Exp Ther. 2009 Nov; 331(2):340-8.
    View in: PubMed
    Score: 0.003
  78. Angiotensin II-induced cyclooxygenase 2 expression in rat aorta vascular smooth muscle cells does not require heterotrimeric G protein activation. J Pharmacol Exp Ther. 2009 Jul; 330(1):118-24.
    View in: PubMed
    Score: 0.003
  79. Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor. Biochemistry. 2009 Feb 24; 48(7):1462-73.
    View in: PubMed
    Score: 0.003
  80. c-Src-mediated phosphorylation of AP-2 reveals a general mechanism for receptors internalizing through the clathrin pathway. Cell Signal. 2009 Jan; 21(1):103-10.
    View in: PubMed
    Score: 0.003
  81. Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes. J Clin Endocrinol Metab. 2008 May; 93(5):1893-900.
    View in: PubMed
    Score: 0.003
  82. Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J Biol Chem. 2007 Oct 05; 282(40):29549-62.
    View in: PubMed
    Score: 0.003
  83. Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. Mol Immunol. 2007 May; 44(12):3092-9.
    View in: PubMed
    Score: 0.003
  84. Identification of a putative nuclear localization sequence within ANG II AT(1A) receptor associated with nuclear activation. Am J Physiol Cell Physiol. 2007 Apr; 292(4):C1398-408.
    View in: PubMed
    Score: 0.003
  85. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem. 2006 Apr 21; 281(16):10856-64.
    View in: PubMed
    Score: 0.002
  86. Arrestin-mediated ERK activation by gonadotropin-releasing hormone receptors: receptor-specific activation mechanisms and compartmentalization. J Biol Chem. 2006 Feb 03; 281(5):2701-10.
    View in: PubMed
    Score: 0.002
  87. Beta-arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitization. Mol Endocrinol. 2005 Apr; 19(4):1078-87.
    View in: PubMed
    Score: 0.002
  88. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation. 2003 Sep 30; 108(13):1611-8.
    View in: PubMed
    Score: 0.002
  89. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci U S A. 2003 Sep 16; 100(19):10782-7.
    View in: PubMed
    Score: 0.002
  90. Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1 adrenergic receptor endocytosis through different pathways. J Biol Chem. 2003 Sep 12; 278(37):35403-11.
    View in: PubMed
    Score: 0.002
  91. beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis. J Biol Chem. 2000 Apr 14; 275(15):11312-9.
    View in: PubMed
    Score: 0.002
  92. Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines. J Urol. 2000 Mar; 163(3):1027-32.
    View in: PubMed
    Score: 0.002
  93. Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases. J Biol Chem. 1999 Jun 04; 274(23):15971-4.
    View in: PubMed
    Score: 0.002
  94. The beta3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism. J Biol Chem. 1999 Apr 23; 274(17):12017-22.
    View in: PubMed
    Score: 0.002
  95. Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J Biol Chem. 1999 Feb 19; 274(8):4749-53.
    View in: PubMed
    Score: 0.002
  96. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 1999 Jan 29; 283(5402):655-61.
    View in: PubMed
    Score: 0.002
  97. Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J Biol Chem. 1999 Jan 15; 274(3):1185-8.
    View in: PubMed
    Score: 0.002
  98. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem. 1998 Jan 09; 273(2):685-8.
    View in: PubMed
    Score: 0.001
  99. G-protein-coupled receptors and their regulation: activation of the MAP kinase signaling pathway by G-protein-coupled receptors. Adv Second Messenger Phosphoprotein Res. 1997; 31:263-77.
    View in: PubMed
    Score: 0.001
  100. Mitogenic signaling via G protein-coupled receptors. Endocr Rev. 1996 Dec; 17(6):698-714.
    View in: PubMed
    Score: 0.001
  101. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J Biol Chem. 1994 Jun 03; 269(22):15776-85.
    View in: PubMed
    Score: 0.001
  102. Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase. Proc Natl Acad Sci U S A. 1994 Apr 26; 91(9):3637-41.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.